US Patent 7091319 IL-3 variant hematopoiesis fusion protein

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+10 properties)

Infobox

Patent Inventor Names

Alan Michael Easton0

Barbara Kure Klein0

John Patrick McKearn0

John Warren Thomas0

Kumnan Paik0

Marie Helena Caparon0

Mark Allen Abrams0

Peter O. Olins0

S. Christopher Bauer0

Sarah Ruth Braford-Goldberg0

Edits on 29 Aug, 2023

"Add patent abstract"

Golden AI

edited on 29 Aug, 2023

Edits made to:

Article (+498 characters)

Article

Patent abstract

The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin or IL-3 variant. These hIL-3 variants contain amino acid substitutions and may also have amino acid deletions at both the N- and C-termini. The invention also relates to pharmaceutical compositions containing the fusion molecules and methods for using them.

Edits on 19 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 19 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=070913190

Edits on 18 May, 2023

"Remove leading 0 from patent number"

Golden AI